Results 11 to 20 of about 1,251,182 (207)

Risk of Cardiovascular Death in Osteosarcoma

Journal of the College of Physicians and Surgeons Pakistan, 2023
To assess the risk of cardiovascular mortality (CVM) in patients with osteosarcoma.Descriptive study. Place and Duration of the Study: Department of Orthopaedics, The People's Hospital of Baoan, Shenzhen, Guangdong, China, from 1st January 2019 to 1st January 2022.Data on patients diagnosed with osteosarcoma, between 1975 and 2019, were obtained from ...
Yukun, Jia, Yu, Xiong, Zhan, Peng, Guangye, Wang   +3 more
openaire   +2 more sources

Implantation of Hypoxia-Induced Mesenchymal Stem Cell Advances Therapeutic Angiogenesis

Stem Cells International, 2022
Hypoxia preconditioning enhances the paracrine abilities of mesenchymal stem cells (MSCs) for vascular regeneration and tissue healing. Implantation of hypoxia-induced mesenchymal stem cells (hi-MSCs) may further improve limb perfusion in a murine model ...
Farina Mohamad Yusoff, Ayumu Nakashima, Ki-ichiro Kawano, Masato Kajikawa, Shinji Kishimoto, Tatsuya Maruhashi, Naoki Ishiuchi, S. Fadilah S. Abdul Wahid, Yukihito Higashi   +8 more
doaj   +1 more source

Sex differences in long QT syndrome

Frontiers in Cardiovascular Medicine, 2023
Long QT Syndrome (LQTS) is a rare, inherited channelopathy characterized by cardiac repolarization dysfunction, leading to a prolonged rate-corrected QT interval in patients who are at risk for malignant ventricular tachyarrhythmias, syncope, and even ...
Nuria Díez-Escuté, Elena Arbelo, Elena Arbelo, Elena Arbelo, Elena Arbelo, Estefanía Martínez-Barrios, Patricia Cerralbo, Sergi Cesar, José Cruzalegui, Freddy Chipa, Victoria Fiol, Irene Zschaeck, Clara Hernández, Oscar Campuzano, Oscar Campuzano, Oscar Campuzano, Georgia Sarquella-Brugada, Georgia Sarquella-Brugada, Georgia Sarquella-Brugada   +18 more
doaj   +1 more source

Clinical course of patients with hypertrophic cardiomyopathy away from tertiary referral care

ESC Heart Failure, 2023
Aims Data on the clinical course of hypertrophic cardiomyopathy (HCM) are mainly derived from tertiary HCM centre studies, and knowledge of clinical outcomes of patients leaving specialty care and returning to local physicians is limited due to gaps ...
Ramin Garmany, J. Martijn Bos, Steve R. Ommen, Michael J. Ackerman, Jeffrey B. Geske   +4 more
doaj   +1 more source

Relationship of Fibroblast Growth Factor 23 With Hospitalization for Heart Failure and Cardiovascular Outcomes in Patients Undergoing Cardiac Surgery

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Fibroblast growth factor 23 (FGF‐23) is crucial in regulating phosphate and vitamin D metabolism and is moreover associated with an increased cardiovascular risk.
Felix Hofer, Andreas Hammer, Ulrike Pailer, Lorenz Koller, Niema Kazem, Eva Steinacher, Barbara Steinlechner, Martin Andreas, Günther Laufer, Johann Wojta, Thomas A. Zelniker, Christian Hengstenberg, Alexander Niessner, Patrick Sulzgruber   +13 more
doaj   +1 more source

Plasma Big Endothelin-1 Level Predicted 5-Year Major Adverse Cardiovascular Events in Patients With Coronary Artery Ectasia

Frontiers in Cardiovascular Medicine, 2021
Background: Coronary artery ectasia (CAE) is found in about 1% of coronary angiography and is associated with poor clinical outcomes. The prognostic value of plasma big Endothelin-1 (ET-1) in CAE remains unknown.Methods: Patients with angiographically ...
Zhongxing Cai, Zhongxing Cai, Haoyu Wang, Haoyu Wang, Sheng Yuan, Sheng Yuan, Dong Yin, Weihua Song, Kefei Dou, Kefei Dou   +9 more
doaj   +1 more source

Prognostic Value of Serum Galectin-3 in Chronic Heart Failure: A Meta-Analysis

Frontiers in Cardiovascular Medicine, 2022
ObjectiveTo evaluate the association between serum galectin-3 and all-cause death (ACD) and cardiovascular death (CVD) in patients with chronic heart failure (CHF).MethodsThe PubMed and Embase databases and Clinical Trials Registry (www.clinicaltrials ...
Zhendong Cheng, Zhendong Cheng, Kefeng Cai, Chaoxian Xu, Qiong Zhan, Qiong Zhan, Qiong Zhan, Xingbo Xu, Dingli Xu, Dingli Xu, Dingli Xu, Qingchun Zeng, Qingchun Zeng, Qingchun Zeng   +13 more
doaj   +1 more source

Cardiovascular-Related Death Risk Factors in Hypertensive Patients: Indonesia Family Life Survey 2000-2014

International Journal of Integrated Health Sciences, 2021
Objective: To determine the characteristics of the risk factors of cardiovascular death in hypertensive patients in Indonesia based on the Indonesian Family Life Survey (IFLS) longitudinal data.
Rudi Supriyadi, David Paranoan, Yulia Sofiatin   +2 more
doaj   +1 more source

Liraglutide and renal outcomes in type 2 diabetes [PDF]

, 2017
In a randomized, controlled trial that compared liraglutide, a glucagon-like peptide 1 analogue, with placebo in patients with type 2 diabetes and high cardiovascular risk who were receiving usual care, we found that liraglutide resulted in lower risks ...
Brown-Frandsen, Kirstine, Buse, John B., Mann, Johannes F. E, Maranghi, M., Marso, Steven P, Poulter, Neil R, Rasmussen, Søren, Tornøe, Karen, Zinman, Bernard, Ørsted, David D   +9 more
core   +2 more sources

Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT [PDF]

, 2016
Aims In heart failure, non-adherence increases events; in turn, the effect of hospitalization on adherence is incompletely understood. We explored the relationship of non-adherence to outcomes, hospitalizations with non-adherence, and the influence of
Alosco, Ambardekar, Ammassari, Balkrishnan, Böhm, Böhm, Böhm, Chobanian, Claxton, Coronary Drug Project Research Group, De Geest, Ewen, Fang, Fitzgerald, Ford, Gislason, Goldberg, Granger, Havranek, Ho, Horwitz, Jong, Laufs, Masoudi, Mazzaglia, McMurray, Mosterd, Osterberg, Rasmussen, Roger, Simpson, Swedberg, Swedberg, Vrijens, Wu, Yue   +35 more
core   +1 more source